OPTIMISING RURAL MUSCULOSKELETAL HEALTH
Adnan Asger Ali, PhD candidate
The University of Sydney &
Director & Principal Physiotherapist
Accelerate Physiotherapy, Canberra, Australia &
Chair of Business and Finance Committee,
International Federation of Manual and Musculoskeletal Physical Therapists Incorporated (IFOMPT) &
Chair, National Musculoskeletal Committee,
Australian Physiotherapy Association
RESEARCHER PROFILE
Filmed in Canberra, Australia | September 2025
Adnan Asger Ali is a Director of Accelerate Physiotherapy and PhD candidate at The University of Sydney, where he is researching implementation strategies for musculoskeletal care pathways in rural Australia as part of the PACE-RURAL project.
Graduating from The University of Canberra, Adnan completed a Masters in Musculoskeletal Physiotherapy at La Trobe University and a Masters in Pain Management at The University of Sydney. He is one of few physiotherapists in Australia holding dual APA titles as both Musculoskeletal and Pain Physiotherapist.
A passionate advocate for physiotherapy, Adnan serves as Chair of the Australian Physiotherapy Association’s National Musculoskeletal Committee and sits on the Capital Health Network’s Clinical Council. His commitment to clinical excellence was recognised when he received Physiotherapist of the Year at the 2023 Allied Health Awards.
Adnan has extensive sports physiotherapy experience, currently working with Tennis Australia treating professional players on international tours and at The Australian Open. Through his research and clinical practice, he is dedicated to improving access to evidence-based musculoskeletal care for all Australians.
Source: Supplied
-
Pancreatic and lung cancers driven by mutations in the cancer gene KRAS
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Liver cancer & patient-derived tumour organoids
Dr Benjamin Dwyer is a translational cancer researcher driven by a clear purpose: to ensure discoveries made in the laboratory genuinely improve outcomes for patients.
Based at Curtin University, he established and now leads the organoid platform within the Liver Cancer Collaborative and directs the WA Organoid Innovation Hub, working at the intersection of biology, medicine and biotechnology to accelerate new treatments for liver cancer.
-
Novel forms of brain stimulation & psychedelic assisted psychotherapy
Professor Paul Fitzgerald is the Head of the School of Medicine and Psychology at the Australian National University. He is an academic psychiatrist with a MBBS degree, Masters of Psychological Medicine and research PhD. He has conducted an extensive range of experimental studies and clinical trials, focused on the development of novel treatment options for patients with mental health conditions such as depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease.
